Soil bacteria make cocktails of molecules that synergistically inhibit the growth of microbial pathogens — suggesting a ...

Lakewood-Amedex Biotherapeutics Inc., (NASDAQ: LABT, the "Company"), a clinical-stage biotechnology company advancing a novel ...

Four antibiotic compounds produced in Streptomyces bacteria attack multiple parts of an essential metabolic pathway.

A Monash University-led study has found that an unusual pairing of two commonly used antibiotics can kill and stop the spread ...

By Bhanvi Satija and Sriparna Roy June 17 (Reuters) - The U.S. FDA has approved GSK's oral antibiotic to treat complicated urinary tract infections, the regulator said on Wednesday, giving patients a ...

Companies are aggressively marketing home medical kits containing prescription antibiotics and other drugs for self-treatment ...

A new warning has been issued for a type of penicillin used across the UK. The Medicines and Healthcare products Regulatory ...

Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company") is a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for difficult-to-treat bacterial ...

Introduction Antimicrobial stewardship efforts in low- and middle-income countries (LMICs) largely focus on qualified ...

Generic approved as part of combination regimens for active and latent pulmonary TB ...

Through trend analyses, this surveillance highlighted both the emergence and decline of AMR across diverse bacterial pathogens, helping inform which antibiotics may remain appropriate as first-line ...

Periodontitis remains a major global health challenge, but better outcomes depend on consensus in diagnosis, collaboration ...